HOME >> MEDICINE >> NEWS
Rare heart problem decreases in clot-busting era

"Even though less than 1 percent of patients who undergo fibrinolytic therapy will suffer from cardiac tamponade, it is still a catastrophic event and potentially life-threatening," Patel said. "The time from symptom onset to treatment strongly predicts the development of tamponade, which underscores the need for continuing efforts to rapidly treat patients having an acute heart attack."

For their analysis, the Duke pooled the clinical data from seven multi-center international trials designed to evaluate different fibrinolytic agents from 1990-2002. Out of the population of 102,060 acute heart attack patients who were enrolled in the trials, 865, or 0.85 percent, developed cardiac tamponade during their hospitalization.

On average, the patients who suffered cardiac tamponade tended to be older (71.9 vs. 61.6 years old); were more likely to be female (54 percent vs. 25.1 percent), and were more likely to have suffered an attack on the front wall of the heart (61.9 percent vs. 41.5 percent). Additionally, the researchers found that tamponade patients waited longer 3.5 hours vs. 2.8 hours before the initiation of fibrinolytic therapy.

"Knowing which patients are more at risk for cardiac tamponade should make it easier for physicians to prevent it from happening," Patel continued. "The strongest predictor that physicians can affect was how long it took for fibrinolytic treatment to begin. The key is providing blood flow to the infarcted heart as soon as possible."

Patel recommends that patients who are at increased risk for tamponade should undergo routine cardiac ultrasound to detect any signs of fluid accumulation in the pericardium. To help physicians, Patel is developing a "nomogram," or health care flow chart, in which physicians taking care of heart attack patients can enter different patient characteristics into an algorithm that can quickly identify patients at the highest risk for tamponade.

Tamponade is also com
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
9-Nov-2004


Page: 1 2 3

Related medicine news :

1. New study in Nature demonstrates protection against cell death during heart attack
2. Uric acid and heart disease
3. Researchers search for first sign of congestive heart failure
4. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
5. Extreme exertion, emotion can spark repeat heart attacks
6. Men with severe sleep breathing disorder have higher risk of heart problems
7. Red wine protects the heart
8. Yale authors raise concerns regarding regionalized heart attack care
9. Community-based care beats standard clinic in lowering heart
10. Blacks less likely to get expensive, newer heart treatments
11. Vitamin E may not prevent cancer or cardiovascular events, but may increase risk for heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
Breaking Medicine Technology:
Cached News: